Are there any therapies accessible for COVID-19?

The Food and Drug Administration has approved the antiviral drug remdesivir for treating certain patients who are hospitalized for COVID-19—specifically, adults and children age 12 years and older who weigh at least 108 pounds.

In addition, the National Institutes of Health (NIH) has developed treatment guidelines for COVID-19. The guidelines, which will be updated as experts learn more about the disease, include recommendations on antiviral drugs, as well as other treatments such as convalescent plasma and dexamethasone. Talk to your healthcare professional about treatments that may be available for you.